MedPath

Effects of Dehydroepiandrosterone on ovary.

Phase 2
Conditions
Diseases of the genitourinary system.
Female infertility
Complications associated with artificial fertilization
N97
N98
Registration Number
IRCT2017091529374N1
Lead Sponsor
Vice chancellor of Mazandaran University of Medical Science.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
70
Inclusion Criteria

Infertile women aged 20 to 45 years; normal hysterosalpingography; AMH levels < 1.5 ng/ml; antral follicular counts (AFC) < 7 in both ovaries; prior less than three failed in vitro fertilization cycles. Exclusion criteria: Normal ovarian response in ovulatory cycles or in vitro fertilization cycles.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anti-mullerian hormone rate. Timepoint: Before intervention, six weeks after intervention. Method of measurement: Laboratory kits.;Clinical pregnancy rates. Timepoint: Forth weeks after embryo transfer. Method of measurement: Questionnare.
Secondary Outcome Measures
NameTimeMethod
Miscarriage rates. Timepoint: Till twenty weeks after embryo transfer. Method of measurement: File.;Antral Follicular counts. Timepoint: Before treatment, six weeks after treatments. Method of measurement: ultrasonography.
© Copyright 2025. All Rights Reserved by MedPath